Terms ending in 2036
Bayer Pharma Aktiengesellschaft
Every in-force patent on Bayer Pharma Aktiengesellschaft's record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,316,001 | Method for Producing (4S)-4-[4-Cyano-2-(METHYLSULFONYL)PHENYL]-3,6-Dimethyl-2-OXO-1-[3-(TRIFLUOROMETHYL)PHENYL]-1,2,3,4-Tetrahydro PYRIMIDINE-5-Carbonitrile In force · High confidence | PH Pharma Co. Ltd. | In force | High confidence | |
| US 10,584,167 | ANTI-CEACAM6 Antibodies and Uses Thereof In force · High confidence | Bayer Pharma Aktiengesellschaft | In force | High confidence | |
| US 11,866,495 | ANTI-CEACAM6 Antibodies and Uses Thereof In force · Medium confidence | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | In force | Medium confidence | |
| US 10,137,209 | New Gadolinium Chelate Compounds for Use in Magnetic Resonance Imaging In force · High confidence | Bayer Pharma Aktiengesellschaft | In force | High confidence | |
| US 10,722,601 | Gadolinium Chelate Compounds for Use in Magnetic Resonance Imaging In force · High confidence | Bayer Pharma Aktiengesellschaft | In force | High confidence | |
| US 10,975,060 | High Relaxivity Gadolinium Chelate Compounds for Use in Magnetic Resonance Imaging In force · High confidence | Bayer Pharma Aktiengesellschaft | In force | High confidence | |
| US 11,491,245 | Gadolinium Chelate Compounds for Use in Magnetic Resonance Imaging In force · High confidence | Bayer Pharma Aktiengesellschaft | In force | High confidence | |
| US 11,814,369 | High Relaxivity Gadolinium Chelate Compounds for Use in Magnetic Resonance Imaging In force · Low confidence | Bayer Pharma Aktiengesellschaft | In force | Low confidence | |
| US 12,478,696 | Gadolinium Chelate Compounds for Use in Magnetic Resonance Imaging In force · High confidence | Bayer Pharma Aktiengesellschaft | In force | High confidence | |
| US 10,435,403 | Positive Allosteric Modulators of Muscarinic M2 Receptor In force · High confidence | Bayer Pharma Aktiengesellschaft | In force | High confidence | |
| 18 more term ends in 2036 · Pro | |||||
10 of 28 patents shown. Soonest term end first, then patent number.
Pro members see all 28.
26 of these are in force and held by Bayer Pharma Aktiengesellschaft.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.